These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 12189209)

  • 1. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy.
    Abu-Baker A; Messaed C; Laganiere J; Gaspar C; Brais B; Rouleau GA
    Hum Mol Genet; 2003 Oct; 12(20):2609-23. PubMed ID: 12944420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
    Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
    J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PolyQ fibrillation in the cell nucleus: who's bad?
    von Mikecz A
    Trends Cell Biol; 2009 Dec; 19(12):685-91. PubMed ID: 19796946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HSPB7 is the most potent polyQ aggregation suppressor within the HSPB family of molecular chaperones.
    Vos MJ; Zijlstra MP; Kanon B; van Waarde-Verhagen MA; Brunt ER; Oosterveld-Hut HM; Carra S; Sibon OC; Kampinga HH
    Hum Mol Genet; 2010 Dec; 19(23):4677-93. PubMed ID: 20843828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
    Kubota H; Kitamura A; Nagata K
    Methods; 2011 Mar; 53(3):267-74. PubMed ID: 21195182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyglutamine and polyalanine expansions in ataxin7 result in different types of aggregation and levels of toxicity.
    Latouche M; Fragner P; Martin E; El Hachimi KH; Zander C; Sittler A; Ruberg M; Brice A; Stevanin G
    Mol Cell Neurosci; 2006 Mar; 31(3):438-45. PubMed ID: 16325416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV; Lazarev VF; Kaznacheeva AV; Ippolitova MV; Muronetz VI; Kinev AV; Margulis BA
    Hum Mol Genet; 2011 Oct; 20(20):3953-63. PubMed ID: 21775503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome degrades soluble expanded polyglutamine completely and efficiently.
    Michalik A; Van Broeckhoven C
    Neurobiol Dis; 2004 Jun; 16(1):202-11. PubMed ID: 15207277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM; Bottomley SP
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins.
    Krobitsch S; Lindquist S
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1589-94. PubMed ID: 10677504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution in a proteasome subunit triggers aggregation of ubiquitinated proteins in stressed neuronal cells.
    Li Z; Arnaud L; Rockwell P; Figueiredo-Pereira ME
    J Neurochem; 2004 Jul; 90(1):19-28. PubMed ID: 15198663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded polyglutamines impair synaptic transmission and ubiquitin-proteasome system in Caenorhabditis elegans.
    Khan LA; Bauer PO; Miyazaki H; Lindenberg KS; Landwehrmeyer BG; Nukina N
    J Neurochem; 2006 Jul; 98(2):576-87. PubMed ID: 16805848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in understanding the pathogenesis of polyglutamine diseases: involvement of molecular chaperones and ubiquitin-proteasome pathway.
    Jana NR; Nukina N
    J Chem Neuroanat; 2003 Oct; 26(2):95-101. PubMed ID: 14599658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of impaired proteasomal function in a cellular model of polyglutamine diseases.
    Jana NR; Nukina N
    Methods Mol Biol; 2004; 277():287-92. PubMed ID: 15201463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum chaperone GRP78 suppresses the aggregation of proteins containing expanded polyglutamine tract.
    Yamagishi N; Magara S; Tamura S; Saito Y; Hatayama T
    Biochem Biophys Res Commun; 2012 Jun; 422(3):527-33. PubMed ID: 22627132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat.
    Nishikori S; Yamanaka K; Sakurai T; Esaki M; Ogura T
    Genes Cells; 2008 Aug; 13(8):827-38. PubMed ID: 18782221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
    Díaz-Hernández M; Valera AG; Morán MA; Gómez-Ramos P; Alvarez-Castelao B; Castaño JG; Hernández F; Lucas JJ
    J Neurochem; 2006 Sep; 98(5):1585-96. PubMed ID: 16787406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
    Popiel HA; Nagai Y; Onodera O; Inui T; Fujikake N; Urade Y; Strittmatter WJ; Burke JR; Ichikawa A; Toda T
    Biochem Biophys Res Commun; 2004 May; 317(4):1200-6. PubMed ID: 15094397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface plasmon resonance characterization of specific binding of polyglutamine aggregation inhibitors to the expanded polyglutamine stretch.
    Okamoto Y; Nagai Y; Fujikake N; Akiko Popiel H; Yoshioka T; Toda T; Inui T
    Biochem Biophys Res Commun; 2009 Jan; 378(3):634-9. PubMed ID: 19061859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.